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INTRODUCTION
Previous communications by Frei, Sulzberger and others, as
well as by the present author (1 a to h, 2, 3, 4) have called atten-
tion to certain features of cutaneous arsphenamine hypersensi-
tiveness as it exists in guinea-pigs, and to differences from that
seen clinically in man.
In the guinea-pig an obvious initial cutaneous depot of arsphenamine is an
essential perquisite, if sensitization is to develop (Sulzberger (id)). In man
sensitivity develops much more easily, not only after accidental paravenous in-
jection, but also when no obvious local deposit has occurred. It would naturally
be expected that sensitization from a local focus would be of higher degree than
that developed after intravenous injections. However, in the course of ordinary
therapeutic administration in man, not only does the frequency of the systemic
sensitizing effect of arsphenamine greatly overshadow that of local tissue irrita-
tion, but many ill defined collateral factors influence the sensitization process, and
apparently prevent its development.
Signs of developing sensitization appear after a short incubation period, and in
the guinea-pig are often manifested as a local skin reaction to residual arsphen-
amine. In man sensitization is first suggested by the development of severe
pruritus in rather constant localizations, and can often be verified by patch test
before the actual appearance of the cutaneous eruption.
That the entire integument is sensitized in both man and guinea-pigs is at-
tested by the development of positive patch tests in one and intradermal reactions
in the other. The degree of general sensitivity, however, is definitely higher in
man, for when an intravenous injection of arsphenamine is given in a sensitized
subject often a general or, at least, a wide-spread reaction occurs. In the guinea-
'From the Section on Dermatology, Department of Medicine, Royal Victoria
Hospital.
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pig an intravenous injection frequently results in a "flare-up" oniy at the site of
the previous intradermal injection. At times the sites of both the initial and the
test (second) injections may flare up in the guinea-pig.
This difference is a little difficult to understand, although the guinea-pig re-
sponds to intradermal injections only, and man characteristically to patch tests
as well.2 Furthermore, the erythematous and edematous nature of the reaction
to the second test iijection in guinea-pigs, contrasts sharply with the erythemato-
vesicular epidermal reaction to the patch test in man. Yet, despite the greater
proximity and accessibility of the reacting tissue of the guinea-pig to the intra-
venous injection, the reaction is often conspicuously local, at the point of previous
immediate cellular contact with injected arsphenamine. Whether or not this
difference is only one of degree of sensitization can only be conjectured, but it is
possible that some fundamental difference is present. Further studies of these
differences, along the lines suggested by Landsteiner (5), would be of interest.
Despite these differences in severity of the degree of sensitization in the two
instances, certain similarities may be observed. In both the experimental sensi-
tization of the guinea-pig and in the clinical dermatitis in man, the variation in
reaction to different preparations, and to different lots of the same preparation,
can be noted (if, h). This variability may perhaps be due to the ease with which
conjugated body protein-arsphenamine antigens can be formed. In man, how-
ever, the sensitivity may extend to tryparsamide (6), which is apparently in-
capable of sensitizing guinea-pigs.
Another striking similarity is the influence of vitamin C on the cutaneous
reactions. In guinea-pigs the reactions can be made to appear and disappear at
will, by varying the vitamin C content of the diet. A high vitamin C diet in-
hibits the cutaneous reactions, as first shown by Sulzberger and Oser (ig). That
this phenomenon is not a suppression of the development of sensitization was
shown by the present author, by sharply decreasing the vitamin C content of the
diet in previously sensitized animals, whose reactions had been inhibited by large
doses of the vitamin. Retesting then frequently gave the 24—48 hour reaction of
existing sensitivity.
Unpublished experiments by the author in man have given similar, although
less spectacular results. In six cases with early post-arsphenamine dermatitis,
the cutaneous eruptions greatly improved when large doses of vitamin C were
given, although, paradoxically enough, the degree of associated pruritus was
often extreme. In two out of three cases of previous dermatitis with positive
patch tests, the same type and lot of arsphenamine was resumed without further
reaction, when the patient was first prepared by the injection of large doses of
2 It should be recalled that in man the reaction of sensitivity may at times be
elicited by both patch- and intradermal tests; for example, as in arsphenaxnine
dermatitis, in skin tuberculosis, and in dermatophytosis. The intradermal
reactions are of the delayed cellular, in contra-distinction to the acute urticarial
type. This crossed reactivity is the exception rather than the rule, however,
and only serves to focus attention more strongly on probable fundamental differ-
ences in the reacting mechanism to the two methods of testing. In one it is
assumed that primarily the epidermal cells are tested, while in the other the
allergen certainly penetrates to the dermis.
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vitamin C intravenously. Here again, however, a difference in technique was
present; in man the resumption of arsenical therapy was effected with initially
minute doses intravenously, and it is possible that some desensitization to the
conjugated antigen was taking place. In the two cases in whom the intravenous
therapy was resumed without further dermatitis, the patch-tests remained posi-
tive, but were of diminished intensity. Since the epidermal cells were still defi-
nitely sensitive it may be that the vitamin C prevented the intravenously circu-
lating arephenamine from coming in contact with the sensitized epidermal cells.
A more probable explanation is that despite the positive patch-test, the capacity
of the cells for specific reactiveness had diminished, and the relatively small
amount of intravenously conferred arephenamine was insufficient to elicit the
epidermal reaction. That this latter explanation may be in part true is sug-
gested by the inhibitory action of vitamin C, as demonstrated by the negative
intradermal reaction to neoarsphenamine in previously sensitized guinea-pigs.
Since in this instance the arspheriamine is in intimate contact with the sensitized
cells, which, nevertheless, do not react, either the arephenamine has not combined
with its conjugating tissue-protein to form a potent antigen, or (if it acts as a
haptene), its oxidation, or the reacting capacity of the cells has been inhibited.
The mechanism with which vitamin C affects cutaneous arsphenamine sensi-
tiveness is unknown. One is tempted to think of the marked action of the vitamin
on capillary endothelium, maintaining its integrity, and preventing toxic effects
on perivascular structures. The more marked action of the vitamin in the
guinea-pig (excluding quantitative differences in degree of sensitization) might
possibly be explained by the fact that deeper dermal structures are involved in
the reacting mechanism (positive intradermal tests and negative patch tests—
erythematous and edematous nature of the reaction). Vitamin C may have an
inhibitory action on the oxidation of neoarsphenamine, thus exerting a mediat-
ing influence on the specific reaction.
The susceptibility of guinea-pigs to anaphylaxis would lead one to believe that
possibly the allergic response is not entirely confined to the skin, as it apparently
is in man (7). However, Schultz-Dale experiments were entirely negative in the
guinea-pig (4), indicating that the sensitivity developed was of the delayed
cellular type (fixed antibodies?), rather than of the anaphylactic type with circu-
lating antibodies and smooth muscle reactivity. The vitamin C content of the
diets was a further complicating factor in the Schultz-Dale experiments, since a
vitamin C deficient diet has been shown (8) to render the uterine strips non-
reactive to pituitary, histamine or horse serum. A high vitamin C diet may also
have an inhibitory effect on smooth muscle contracture, although the literature is
not unanimous on this point (9, 10).
MATERIALS AND METHODS OP THE PRESENT STUDY
Young, adult male guinea-pigs weighing from 300 to 350 grams were used.
The diet was a constant factor, and consisted of hay, oats, beets, carrots, and
water. The experiments were performed in the winter months, unless otherwise
designated. The neoarsphenamine used was uniform with a brand formerly
found to have a high sensitization index.
The technique of sensitization with neoarsphenamine was that used in former
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experiments (la to h). Reactions were tabulated as: 1+ erythema, 1 cm. in
diameter; 2+ erythema, 2 cm. in diameter; 3+ erythema, quarter sized erythema
with small central edema; and 4+ silver dollar (or larger) erythema with large
area of central edema.
Reactions indicative of developing sensitization frequently occurred at the
injected site from 6 to 14 days after the initial injection; they were erythematous,
then became papular, with subsequent gradual disappearance during the ensuing
two weeks. The local reactions to the test (second) dose developed within a 3
day period, were erythematous, often edematous, then papular or nodular, with
gradual involution.
The method of administration of the "staphylococcus toxin" andthe induction
of the streptococcal infection, will be described in the body of the experiments.
EXPERIMENTS
These experiments were performed as a control on a previous experiment, in
which an attempt was made to determine the effect, if any, of the simultaneous
injection of neoarsphenamine and a staphylococcus toxin of known potency, on
the development of arsphenamine sensitization in the guinea-pig. At that time
sensitization to arsphenamine could not be developed, or if present was not
demonstrable by cutaneous testing. The influence of the toxin was negligible;
in fact, it semed as if there was some other factor operating to prevent the
development of cutaneous reactions. Since the previous experiment was per-
formed during the summer months, at which time the vitamin C content of the
diet was high, the possibility that the vitamin C had inhibited the cutaneous
reactions was considered. In a later control experiment (3), using varying
amounts of vitamin C in the diet it was found that large amounts of vitamin C
did suppress the cutaneous reactions.
However, it seemed desirable to repeat the toxin work, using in the first experi-
ment large amounts of vitamin C and in the second a vitamin C deficient diet.
Experiment!. 22 pigs were placed on the Standard Scorbutoginic diet, but
in addition each pig was fed huge amounts of vitamin C. 50 mgrns. daily, or
about 250 times the minimal amount necessary to prevent scurvy. Cod liver oil,
0.2 gms. was given once weekly to each pig.
Method. (1) All pigs were given an initial intradermal injection, which con-
sisted of a mixture of 0.1 cc. of a solution of neoarsphenamine (containing 0.00015
gram) and 0.05 cc. of a 7000 unit strength of Burnett Staphylococcus toxin.
(2) Fresh staphylococcus toxin in the same dosage was then injected intra-
dermally at weekly intervals for three injections.
(3) Neoarsphenamine 0.1 cc. (0.00015 gram) was again injected intradermally,
28 days after the initial injection.
Results. The occurrence of local flare-ups to the initial injection of neo-
arsphenamine could not be determined, due to the necrotizing local reaction of
the toxin. The reactions to the toxin were in every way similar to those described
in the initial toxin-neoarsphenamine experiments (2). There were no reactions
to the second intradermal injection of neoarsphenamine, indicating an absence
of or a suppression of the cutaneous manifestation of sensitization. The only
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demonstrable effect of the toxin injections was a slight general debilitation and a
moderate loss of weight. Any possible augmenting effect in the development of
arephenamine sensitiveness was more than offset by the inhibiting effect of the
large doses of vitamin C or the cutaneous reactions. That this latter influence is
a suppression of cutaneous reactivity, rather than an actual inhibition of sensiti-
zation, has been strongly suggested in previous experiments on the influence of
vitamin C on the production of arsphenamine sensitiveness (3).
Experiment . As a final check on the previous experiments with staphylo-
coccus toxin, a group of 18 pigs were placed on a diet of hay, oats, carrots, beets,
water, and cod liver oil. Since the experiment was performed in March, this diet
was admittedly low in vitamin C. A further complicating factor in the previous
toxin experiments was eliminated; this was the combined injection of the freshly
mixed neoarsphenamine-toxin mixture. The rapid necrotic action of the toxin
undoubtedly destroyed some of the locally deposited neoarsphenamine; and so,
in this experiment the neoarsphenamine was injected in an individual site, so
that absorption would be complete.
To be sure of an adequate toxic effect, a fresh toxin of marked potency was used
for each injection. Large reactions were generated and as soon as these started
to involute fresh toxin in an increased dosage was injected. By this method the
guinea-pigs were kept thin and dibilitated through the experiment.
As a preliminary measure 5 guinea-pigs were given test doses of the toxin,
0.05 cc. of a toxin having an anti-hemolytic titer of 23,400 units per cubic centi-
meter. The reactions were in every way similar to those encountered in the
previous toxin experiments, with cutaneous and subcutaneous necrosis, often
hemorrhagic, and going on to ulceration, crusting and scarring. The reactions
varied in size from that of a cent to a quarter. The pigs became thin and looked
sick.
Method. A group of 18 new pigs were injected intradermally with 0.1 cc. of
toxin, in a 23,400 unit strength. These large doses of toxin produced huge reac-
tions, averaging in size from a quarter to a half dollar. Some were over 2 inches
in diameter. Crusted ulcers formed in about 5 days, and these gradually invo-
luted during the next ten days. On the tenth day after the injection the first
injection of neoarsphenamine was given in an area of normal skin. On the 12th
day 2 pigs died of low grade toxemia and a complicating pneumonia. Fifteen
days after the first injectipn, a second injection of toxin was given, this time in a
dosage of 0.2 cc. Despite the increased dosage, the reactions were slightly
smaller, suggesting that a partial immunity to the toxin was developing. How-
ever, 10 days later large ulcers, and in three instances deep areas of necrosis, were
still present. Fifteen days after the second toxin injection a third injection was
given, this time in 0.3 cc. dosage. Erythematous and elevated lesions developed
and soon became necrotic, ulcerated and crusted. They were similar in size to
those following the previous injection.
During the period following the last toxin injection the pigs were all sick,
their movements were sluggish, and the weight had dropped approximately 25
per cent. Seven days after the last toxin injection, and 28 days after the initial
injection of neoarsphenamine, the second test injection with neoarsphenamine
was given.
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Resutt8 of injection8 with neoar8phenanzine. Of the 16 pigs surviving the
experiment, 12 showed reactions indicative of developing sensitization to the
initial injection. 9 pigs had small papular reactions on the 6th day, 1 on the 7th
day, 1 on the 9th day and 1 on the 13th. There were no 2+ reactions. These
papules involuted slowly, disappearing by the twenty-sixth day.
All of the 16 pigs reacted to the second injection. There were fourteen 1+
reactions and two 2+ reactions. These reactions developed within 18 hours after
injection, reached their height in 24 hours, then began to involute. Involution
was slow, and was not complete until two weeks after the injection.
Comment and COflclu8iofl. All of the pigs of this group became
sensitized to neoarsphenamine, but the reactions were uniformly
mild. They were much less marked than in previous groups of
control pigs (1).
Staphylococcus toxin, even in the presence of a vitamin C low
diet, seemed to have little augmenting influence on the severity
of the reactions to neoarsphenamine. The fact that all pigs
became sensitive was not considered significant, since this had
frequently occurred in control groups (1). The only noticeable
influence was that the reactions were more prolonged than usual.
This may have been in part due to the relatively low vitamin C
content of the diet.
A further complicating factor in the toxin experiments was the inability to
duplicate the clinical conditions obtaining in actual staphylococcal infections in
man. The relatively high natural resistance of the guinea-pig against staphy-
lococci pathogenic for man renders unfair any comparison between the two
situations. Furthermore, the arbitrary use of a toxin, powerful as it may be, is
no substitute for the actual condition obtaining in active infection with staphy-
lococci or streptococci. While the toxin certainly caused loss of weight and
debility, this cathectic effect may have had an exhausting influence on the react-
ing capacity of the animals (See "cachectic anergy" as discussed by Sulzberger
and Oser (1 g) in reference to guinea pigs on a deficient diet. It has been shown
by Swift and Schultz that the augmenting influence of staphylococcus toxin in
the production of beef-lens sensitivity in the rabbit i8 much greater when smaller
doses are used (12)).
Experiments with active streptococcal infection in the guinea-pig
Rational and preliminary discussion. While a virulent toxin
exists a specific depressing and poisonous effect, with frequently
fatal results, when generated in humans, actual infection includes
further effects of species- and type-specific bacterial protein
allergy and presumably still further, as yet unevaluated, effects,
including that of type-specific carbohydrate immunity. In this
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experiment, therefore, an attempt was made to duplicate, as far
as possible, the conditions actually obtaining in streptococcic
infections in man, and to observe the effects, if any, of this experi-
mentally produced infection on the course of arsphenamine
sensitiveness in the guinea-pig.
It is well known that guinea-pigs are extremely susceptible to
certain forms of streptococci. These infections often sweep with
lightening rapidity through a guinea-pig colony, frequently with
a 100 per cent fatality. While the rapidity with which death
occurs varies somewhat in different groups of guinea-pigs, it
usually occurs within 7 days.
The first problem then was to inoculate a series of guinea-pigs
and to observe the course of the infection. Knowing this,
attempts could then be made to attenuate the virulence of the
organism sufficiently to cause a chronic infection in the guinea-
pig, with a delayed fatuity or with an ultimate survival. The
necessity of producing a chronic infection was paramount, as at
least 28 days are necessary to establish the presence and to safely
determine the extent or degree of arsphenamine sensitiveness in
the guinea-pig.
Experiment S. Twenty-two pigs were chosen for the experiment.
Method. All were inoculated subcutaneously in the left flank with 0.5 cc. of
an emulsion of living hemolytie streptococci, Group C, Lancefield, and known to
be pathogenic for guinea-pigs. This organism was known to have produced chronic
infection in guinea-pigs, with abscesses at the site of inoculation and chronic,
purulent, suppurative lymphadenitis. Often wide-spread septicemia occurred
and at times purulent inflammation of the serous cavities developed. However,
the variability of the organism should be stressed, with a marked range in viru-
lence and in its power to produce suppurative adenitis, a feature which was uni-
formly absent in these experiments.
Results. The entire group of pigs died within 20 days. Two pigs died 48 hours
after injection with a massive toxemia. On the third day after injection, the
remaining 20 pigs were losing weight rapidly; they looked sick, and all had large
subcutaneous abscesses at the site of the injection. On the fifth day 7 pigs died,
on the seventh 4, on the eighth 4, on the nineth 3, on the twelfth 1 and on the
twentieth 1. Autopsies uniformly showed a diffuse streptococoic toxaemia.
Group C hemolytic streptococci were recovered from the viscera on culture.
Experiment 4. Twenty pigs were used.
Method. The diet consisted of hay, oats, and green vegetables. Since the
time of the experiment was June—July, this diet was relatively high in vitamin C.
The original strain of streptococci, being found to be too virulent for the pur-
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pose of the experiment, was rendered less virulent by growth in a meat mash
medium.
One-tenth cubic centimeter of an emulsion of these streptococci was given
subcutaneously in the left flank to each pig. At the same time, neoarsphenamine
in the usual dosage was injected intradermally in the opposite flank. The last
dose of neoarsphenamine was injected intradermally 28 days after the initial
injection.
Cour8e of the infection. After 72 hours all but one pig had developed small sub-
cutaneous abscesses, varying in size from that of a pea to a quarter. These
abscesses gradually grew smaller; became flat, infiltrated plaques, then small
papules. On the thirty-first day after injection only one pig had an abscess,
which was quarter-sized. Eleven pigs showed no evidence of the infection,
while the remaining seven had small, involuting papules. One pig died of tox-
emia on the fifth day after injection.
I? eactzon8 to neoar8phenam2ne. Of the 19 pigs that survived the experiment,
only 3 developed delayed reactions, indicative of developing sensitization to the
initial injection of neoarsphenamine. One pig developed an 8 mm. sized papule
on the seventh day. This became 14 mm. sized by the twelfth day, while the
third pig developed a similarly sized papule on the twelfth day. These papules
gradually underwent involution after the fifteenth day.
These same three pigs developed nickel-sized erythemato-edematous reactions
to their test injection of neoarsphenamine. One previously non-reacting pig
gave a similar reaction. Of marked interest was the fact that the only pig which
still had a large abscess at the end of the experiment, did not give a positive reac-
tion to the test injection of neoarsphenamine. These lesions faded rapidly and
disappeared within 4 days. Six months later an autopsy study was made of all
pigs. No evidences of the old streptocoecal infection were found.
Comment and conclusion. Despite the influence of an induced
streptococcal infection, only 4 of this group of 19 pigs were sensi-
tized to neoarsphenarnine. One factor of importance was that
there was an adequate supply of vitamin C in the diet. This may
well have inhibited the development of the cutaneous reactions.
A second factor to be considered was the relative avirulence of
the infection. This may have been in part due to a lowered
pathogenicity of the streptococci. The high vitamin C intake
may have further increased the resistance of the animals, both to
the infection and to the development of hypersensitivity to
arsphenamine.
The results of this experiment suggested the necessity of repeat-
ing the work, using a low vitamin C diet and a streptococcus
which would cause a more virulent infection.
Experiment 5. Materials. Thirty-four pigs were used. The pigs were fed
with hay, oats, beets, carrots and water, and since the experiment was performed
in January—February, this diet was admittedly low in vitamin C.
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Due to the marked virulence of the streptococcal infections in Experiment 3,
and the relatively avirulence of the infection in Experiment 4, the same strain
was given, but in twice the dosage used in Experiment 4.
Induction of infection. All pigs were injected subcutaneously with 0.2 cc. of
the specially prepared emulsion of Group C hemolytic streptococci. These
streptococci were found to be non-pathogenic for the guinea-pig, and no abscess
formation or other evidence of infection occurred. Accordingly, 10 days later a
fresh lot of the same organism was injected in a 0.5 cc. dosage. Again no evidence
of infection developed and so an emulsion of newly prepared Group C strepto-
cocci, whose virulence had been enhanced by animal passage, was injected sub-
cutaneously in a dosage of 0.25 cc. The following day all but one of the 34 pigs
had developed subcutaneous abscesses. These abscesses varied in size, but
averaged that of a quarter. The skin was markedly erythematous, and was fixed
by extension and organization of the abscesses to the underlying tissues. Dur-
ing the next few days, the abscesses, with a few exceptions, began to recede and
be replaced by hard infiltrated plaques and nodules. Two pigs developed large
abscesses 1 inches in diameter. One pig died on the 5th day and autopsy re-
vealed direct extension of the abscess through the abdominal wall, massive peri-
tonitis, and extensive pneumonia. Only 5 of the group of pigs showed evidence of
general toxemia.
On the 5th day all pigs were given an initial intradermal injection of neo-
arsphenamine in the usual dosage.
During the next 7 days the induced infections gradually underwent involution,
and hard nodules and plaques replaced the abscesses. These organized plaques
slowly became smaller. In 2 pigs the abscesses became deep ulcerations. In 6
other pigs the abscesses persisted. Since only 8 pigs showed active abscess forma-
tion on the 13th day, all remaining pigs were reinjected subcutaneously with the
same mixture of streptococci, in a dosage of 0.25 cc.
All of the newly infected pigs developed abscesses within 24 hours after inocu-
lation. These averaged about 2 cm. in diameter, but began to undergo involution
after 2 days, leaving residual papules, hard nodules and plaques at the end of 10
days. At this period, however, 12 of the initially inoculated areas, which had
resulted in abscesses, still showed active infection, varying in diameter from a
cent to a quarter.
In an effort to keep all pigs actively infected during the entire period of de-
velopment of arsphenamine sensitiveness, pus was removed aseptically from the
unopened, large ulcers of 4 pigs. About 2 cc. of pus was obtained; this pus was di-
luted with 4 cc. of normal saline, and injected subcutaneously in a dosage of 0.2 cc.
into the 19 pigs whose infections had subsided. On the following day, all of these
19 pigs had developed abscesses, varying in size from that of a large pea, to a large
walnut. At the end of 9 days, at which time the second test dose of neoarsphen-
amine was given, these abscesses had, in general, decreased but slightly in size2
while in 3 pigs they had become larger. Involution began 4 days later, however,
and the abscesses were replaced by hard nodules and plaques after another 1
days. Two weeks after the 2nd injection of neoarsphenamine one pig continued
to show active abscess formation.
Summary of course of induced infection. This group of pigs was infected with
living streptococci and developed abscesses. The general tendency of the infec-
tion, with a few notable exceptions, was toward spontaneous involution. This
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feature was prominent on re-inoculation. Later during the course of the experi-
ment, purulent material from actively infected pigs was inoculated into all pigs
with subsiding infections, with resultant abscess formation. Thus the entire
group of pigs was kept actively infected during the entire period of attempted
sensitization with neoarsphenamine. During this period they became moderately
debilitated, lost from one-fifth to one-fourth of their body weight, and showed
constitutional evidence of a focus of infection.
RESULTS OF ATTEMPTED SENSITIZATION TO NEOARSPHENAMINE
Reactions to initial injections. Erythematous and then papular
lesions, indicative of developing sensitization, occurred at the
injection site in 23 out of 32 pigs injected. These varied in size
from that of a small pea to a nickel. One appeared on the 7th
day after injection, 15 on the 8th day, 2 on the 9th, 1 on the 10th,
2 on the 13th, and one on the 17th.
TABLE 1






















20 19 1 Healing
J papules3+ 1
Number of reac-
tions 1 16 16 17 20 21 23 21 20 19
These reactions are shown in table 1. The data are summarized
with regard to the intensity of reactions, the number of reacting
pigs, the number of days after injection that the reaction de-
veloped, and the course and involution.
In table 2 the reactions to the test dose of neoarsphenamine are
presented. The data is presented identically with that of table 1.
Of the 30 pigs which were available for the second test injection,
it will be seen that 25 developed sensitization reactions.
Comment. In comparing the reactions elicited by the initial
injection to those previously obtained in normal pigs (1 a to h)
and in pigs on a scorbutogenic diet (3), certain facts stood out.
Twenty-three of the 32 pigs or 71.8 per cent reacted positively,
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indicating that reactions of developing sensitization were easily
obtained when (a) pigs were on a diet moderately low in Vitamin C
and (b) infection was present. These reactions were much slower
in their development than a comparable group of normal pigs,
TABLE 2











1 5 9 7 11 16 4 )
2 5 4 8 10 8 Healing
3 3 4 8 3 1 small pap-
4 1 5 1 1 ules
4+++ 1 1 J
Number of reac-
tions 14 23 25 25 25 4
Average intensity
reaction 1+ 2— 2+ 2— 1+ 1—
Foe. 1. The degree of severity of the local infections, and the initial sensitiza-
tion reactions to neoarsphenamine are shown. In both of these pigs the initially
induced infections had persisted, indicating a relatively low resistance and an
active infection in the pigs. The reactions to neoarsphenamine were erythemato-
nodular, about 2 em. in diameter and can be seen on the right abdomens. The
abscess in the pig in the left side of the illustration was soft, fluctuant and 1 inch
in diameter. The abscess in the other pig had ruptured, forming the large ulcer
seen, but considerable purulent material was still present.
reactions in whom almost inevitably appeared between the 6th
and 14th days after injection. The reactions developed in much
the same time and were of comparable intensity, to those develop-
ing in pigs on a markedly deficient vitamin C diet (3). The
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greatest degree of positiveness occurred on the 13th day, but 3
more pigs showed signs of developing sensitivity between the
13th and 17th days. The reactions were very slow in their evo-
lution, and on the 25th day, 19 of the 32 pigs still showed papules
undergoing involution.
Thirty of the initially injected 32 pigs were available for rein-
jection; 25 of these 30 pigs (83.3 per cent) reacted to the test
injection. Fourteen of the 25 reacting pigs showed definite
erythematous flares within 7 hours of injection, 23 after 24 hours,
and the entire 25 at 48 hours. As will be seen in table 2 the height
of the reactions did not occur until 48 hours. This is definitely
slower than in previous normal controls (la, b, h), maximum
reactions in whom are obtained within 48 hours. While the
intensity of the reactions began to diminish on the 3rd day, com-
plete involution of the lesions did not take place until after 9 days.
This involution was even slower than that seen in previous experi-
ments, using a controlled low vitamin C diet. The time of maxi-
mum intensity of reactions was about the same as that seen in
pigs on a diet low in vitamin C. The intensity of the reactions at
their height was slightly greater than that seen in the vitamin C
experiments (3).
CONCLUSIONS
The combination of a relatively vitamin C-poor diet and an
experimentally produced streptococcal infection produced the
most chronic and the most severe reactions ever obtained by the
author. The marked indolence of the lesions, their slow evolu-
tion, and the frequency of edematous reactions, were striking
features. The conclusion is suggested that a vitamin C-poor
diet influenced the development of sensitization by two mecha-
nisms. First a specific sensitizing influence, by increasing cellular
irritability and specific reactivity and possibly by capillary endo-
thelial damage; and secondly, by increasing the virulance of the
infection. It is well known (13) that large amounts of vitamin C
stimulate antibody formation. Conversely in the presence of a
vitamin C poor diet, antibody formation is inhibited, and the
infection is consequently more active. This inhibition of anti-
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body formation may take on added significance, when one recalls
that the specific deleterious cytotoxic effect shown in combination
immunity can be completely inhibited in tissue culture by the
addition of immune plasma (14). From the above experiment
the conclusion seems inescapable that under proper conditions
(i.e. a vitamin C poor diet) an active infection increases the sever-
ity of sensitization to neoarsphenamine, and that a vitamin C
rich diet inhibits the development of sensitization under these
circumstances. Since in this experiment the infection was of
relatively low grade it is probable that more marked effect might
be observed in the presence of a more active infection. It should
be recalled, however, that the degree of specific hypersensitiveness
may not correspond with the virulence of the infection (11).
GENERAL COMMENT
For years numerous clinical observations have indicated that
many chronic infections in man have stimulated the capacity for
specific altered reactions. Stokes and Cathcart (15) observed
that arsphenamine dermatitis was made worse by intercurrent
infection. In a later paper, Stokes and Kulchar (16) discussed
the possible ramifications between focal infection, fungous disease
and post-arsphenamine dermatitis. Despite many clinical obser-
vations, previous experimental approach to the problem of the
influence of infection on the development of arsphenamine sensi-
tiveness has not been made. The phenomena of "combination
immunity," or of "synergic sensitization" however, are well
known in the literature. Gay and Southard (17), as early as
1907, noted that when a mixture of diphtheria toxin and horse
serum antitoxin contained an excess of toxin, the larger local
reaction was accompanied by an increased production of immune-
bodies. Lewis (18) showed that the anaphylaxis produced in
guinea-pigs with horse serum was much greater when such un-
balanced mixtures were used, than when the antigen was com-
pletely neutralized. Ramon (19) showed that this enhancing
power was at least partially due to local tissue reaction, since a
similar result was obtained by injecting tapioca, and Moro stated
(20) that tuberculin sensitivity had developed in subjects, simul-
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taneously injected with tuberculin in conjunction with vaccine
virus or pig serum. Dienes' interesting work (21) with tuber-
culous guinea-pigs showed that delayed tuberculin-type of skin
sensitization, and delayed tuberculin-like shock to intravenous
injections of egg white, occurred when the egg white was initially
injected into tuberculous peritoneal foci. This enhancing of
allergic reactivity was not entirely due to the local synergetic
tissue effect, for Hanks (22) showed that horse serum could elicit
tuberculin-like cutaneous responses when the tubercule bacilli
were injected in one testicle and the horse serum into the other.
This latter observation was confirmed by Swift and Schultz (12),
in follow up experiments subsequent to Burky's (23) original
work with beef lens and staphylococcus toxin. While Burky
succeeded in sensitizing rabbits with beef lens, by previously
growing staphylococci in beef lens media, and injecting the toxic
filtrate intradermally at intervals, Swift and Schultz were able
to duplicate this result by injecting the toxin and the beef lens
into the opposite flanks of the rabbit, and also in some experi-
ments where the beef lens was injected into the same foci three
hours after the injection of toxin.
Thus the stimulating influence was exerted systemically as well
as focally, and was probably due to the specific irritating effect
of the toxin, rather than the union in vitro of toxin and lens to
form a potent antigen. This is sharp contradistinction to the
"Schlepper" effect of pig serum and lipoidal partial antigens
(Landsteiner), for although here was an irritating effect on mesen-
chymal cells, the serum and lipoid haptenes must be mixed in
vitro and injected together to secure the sensitizing effect. It is
of interest that the combination injections did not cause hyper-
sensitiveness in previously specifically immunized animals. In
considering the effect of the toxin, then, there may be a general
stimulating effect on antibody forming cells, similar focal stimu-
lation of mesenchymal cells, and delayed absorption into the
tissues.
In a subsequent study Swift and Schultz (24) showed that
infection with indifferent streptococci produced a similar although
less marked sensitivity to lens than did staphylococcus toxin, for
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while the cutaneous reactions were large, the ophthalmic reactions
and the precipitin titer were slight to absent. The mechanism
involved in infection with indifferent streptococci is almost cer-
tainly somewhat different than that with staphylococcus toxin.
No demonstrable toxins are produced from indifferent strepto-
cocci, while specific, delayed tuberculin-like tissue hypersensitive-
ness is the rule. Sensitivity to lens develops simultaneously with
the streptococcal sensitization. The nature of the mechanism is
unknown, but the resulting sensitivity is much greater when a
local cutaneous focus is present. The systemic effect, while
present, is less marked. Certainly there is no constant correla-
tion between skin, ophthalmic and precipitin reactions.
This has been confirmed by the important work of Moen on
tissue cultures (11). Tuberculous animals and animals infected
intradermally (sensitized) to Group C hemolytic streptococci
were used. Tissue cultures were made from splenic explants of
infected animals (tuberculosis or chronic streptococcal infection)
and grown in a medium containing tuberculin or hemolytic
streptococcic extract. Specific cytotoxic effects were shown,
which correlated neither with the results of the skin tests or with
the humoral antibody titer.
Lastly, mention must be made of the growing significance of
specific carbohydrate fractions of many organisms, particularly
the pneumococcus (25), the streptococcus (26), the staphylo-
coccus (27) and trichophytons and Monilia. The close connec-
tion between these carbohydrates with immunity on the one
hand, and specific anaphylaxis on the other, is well known, as
well as the identification of this fraction with the virulent principle
of some organisms.
When considering, then, the response of an animal to infection,
(a) a non-type-specific but species-specific tuberculin-like skin
reaction from bacterial protein, (b) a specific carbohydrate
(haptene) reaction, (c) a further type-specific tissue reaction to
bacterial protein (Moen), and often (d) the action of a specific
toxin, must be considered. However, the obvious complexity
of bacterial antigens, the variable development of toxin in dif-
ferent species, and the results obtained under the different
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methods of injection and with the different fractions, render
unfair any comparison between what takes place in actual infec-
tion (with a possible synergistic action of the different fractions)
and what may occur under the former conditions.
In considering the synergic relationship between a complex
organism like the streptococcus and the enhancement of cutaneous
arsphenamine sensitiveness, both a local and a systemic effect
can be postulated. In my experiments the sites of injection of
streptococci and of arsphenamine were at all times separate.
Yet a definite augmenting effect on the degree of arsphenamine
sensitivity was shown. This might possibly have been greatly
enhanced if the injections had been made in the same site simul-
taneously.
Analogously, one might compare the effect of furunculosis in an
area of arsphenamine dermatitis with the "flaring" effect of an
acute streptococcal tonsillitis on the derrnatitic process. It might
be of interest to determine whether or not the different fractions of
the streptococcus exert specific combination effects. However the
failure of such experiments to duplicate the actual clinical condi-
tions would entail the possibility of drawing an entirely mis-
leading conclusion. It may be that specific protein sensitivity
of the delayed type, as confirmed by Moen's work (11), is the
important factor in relation to streptococcal infection and ars-
phenamine sensitiveness. The specific cellular nature, limited
chiefly to the skin (Sulzberger and Bloch (7)), of arsphenamine
dermatitis is in line with this viewpoint, and suggests that the
antigen-soluble antibody reactions of carbohydrate anaphylaxis
and immunity are only secondarily related.
The failure of staphylococcus toxin to exert an augmenting
effect on the development of arsphenamine sensitiveness may be
due to the fact that the guinea-pig, although susceptible to the
dermatonecrotic and to the intravenous lethal effect of staphylo-
coccus toxin, has a high natural resistance against staphylococcus
infection. Toxin would conceivably have a very different action
on the cells of a naturally immune guinea-pig than in man, in
whom the staphylococcus frequently causes local lesions and not
infrequently wide-spread disease. In addition protein fractions
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of the bacterial bodies may exert a specific sensitizing influence
on body cells.
SUMMARY
A series of experiments were performed in an attempt to deter-
mine if injections of staphylococcus toxin, or if experimentally
induced streptococcus infection, exerted a stimulating and aug-
menting influence on the course of arsphenamine sensitization as
produced experimentally in the skin of guinea-pigs.
Staphylococcus toxin did not influence the severity of the
induced cutaneous hypersensitivity to arsphenamine, even when
the diet was low in vitamin C. This result may be in part due to
the relatively high natural immunity of the guinea-pig to staphy-
lococcus infection, with a supression of the stimulating effect of
the toxin on body-cells.
In contrast to this negative result in the presence of a low vita-
min C diet, chronic local infection with the Group C hemolytic
streptococcus definitely accentuated the manifestations of cuta-
neous arsphenamine hypersensitivity. This accentuating effect
was inhibited when the diet was high in vitamin C; and this
was probably due not only to the inhibition of the reactions to
arsphenamine by the vitamin, but also to its effect in stimulating
resistance to the streptococcus infection. The non-specific tonic
and stimulating action of the arsphenamine may have had some
further ameliorating influence on the course of the chronic strepto-
coccus infection.
It is to be remarked that even with the use of a streptococcus
of considerable virulence, only a mild infection could be produced
with safety in the guinea-pig. Slight stepping-up of the virulence
of the organism resulted in septicemia and rapid death.
The modus operandi of the streptococcus infection in influencing
the cutaneous reactivity to arsphenamine in the guinea-pig was
not determined. It is known that in Group C hemolytic strepto-
coccus infections in the guinea-pig, cutaneous hypersensitivity
to crude streptococcus extracts invariably develops (28). That
this reaction may be only a co-incidental phenomenon and not
the essential change in the development of cellular hypersensi-
216 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
tivity was shown by Moen in tissue culture experiments (11).
Similar cutaneous reactivity can often be elicited in man to crude
extracts of the streptococcus; and for example, to the specific
carbohydrates of the staphylococcus (29). This reactivity does
not necessarily mean susceptibility or allergic hyperreactivity to
infection with living organisms; and it is possible that the essential
mechanism will be determined by the extension of Moen's work
to human infections.
However this form of tissue hypersensitivity, by causing specific
cytotoxic effects, may constitute the deleterious effect which aug-
ments the severity of cutaneous arsphenamine hypersensitiveness
in the guinea-pig. This effect, however, being determined by
cytotoic effects on mesenchymal cells may indicate that even
in epidermal sensitization, the irritating mechanism may occur
in the mesenchymal cells of the dermis.
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